Does Rallies show 13F holders for HQY?

Yes. Rallies tracks hedge fund and 13F ownership data for HQY, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HQY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HQY. It does not provide personalized investment advice.

HQY (HealthEquity, Inc) Stock Analysis - Hedge Fund Holdings

HealthEquity, Inc (HQY) is a publicly traded Healthcare sector company. As of May 20, 2026, HQY trades at $87.51 with a market cap of $6.96B and a P/E ratio of 38.91. HQY moved +3.41% today. Year to date, HQY is -6.33%; over the trailing twelve months it is -13.47%. Its 52-week range spans $72.76 to $116.65. Analyst consensus is strong buy with an average price target of $114.40. Rallies surfaces HQY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HQY stock?

Hedge funds tracked by Rallies that own HQY include Viking Global, Bridgewater Associates, Mangrove Partners, Pinebridge Investments, and Polen Capital. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HealthEquity, Inc.

HQY Key Metrics

Key financial metrics for HQY
Metric	Value
Price	$87.51
Market Cap	$6.96B
P/E Ratio	38.91
EPS	$2.21
Dividend Yield	0.00%
52-Week High	$116.65
52-Week Low	$72.76
Volume	1.08M
Avg Volume	0
Revenue (TTM)	$1.29B
Net Income	$191.83M
Gross Margin	67.72%

Top Hedge Funds Holding HQY

Viking Global holds 219.75K shares of HQY, changed +0.00% as of Jun 30, 2025.
Bridgewater Associates holds 20.83K shares of HQY, changed +226.49% as of Dec 31, 2025.
Mangrove Partners holds 8.80K shares of HQY, changed +0.00% as of Mar 31, 2026.
Pinebridge Investments holds 7.84K shares of HQY, changed -71.53% as of Mar 31, 2025.
Polen Capital holds 4.98K shares of HQY, changed -39.59% as of Dec 31, 2025.

Latest HQY News

HealthEquity drops as custodial-cash yield outlook drives renewed rate-sensitivity worries — Apr 28, 2026
HealthEquity jumps as investors revisit raised FY2027 outlook and margin gains — Apr 27, 2026
HealthEquity jumps as year-end HSA assets hit $36.5B and outlook holds — Apr 26, 2026
HealthEquity jumps 6% as BMO upgrades to Outperform, lifts target to $105 — Apr 25, 2026
HealthEquity jumps as raised FY2027 outlook regains focus after leadership changes — Apr 24, 2026

Recent HQY Insider Trades

Ladd Delano sold 1.50K (~$142.08K) on Dec 19, 2025.
Rosner Elimelech sold 10.96K (~$1.05M) on Dec 18, 2025.
Wellborn Gayle Furgurson sold 4.34K (~$425.33K) on Dec 12, 2025.

HQY Analyst Consensus

11 analysts cover HQY: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $114.40.

Common questions about HQY

Who owns HQY stock?: Hedge funds tracked by Rallies that own HQY include Viking Global, Bridgewater Associates, Mangrove Partners, Pinebridge Investments, and Polen Capital. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HealthEquity, Inc.
Does Rallies show 13F holders for HQY?: Yes. Rallies tracks hedge fund and 13F ownership data for HQY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HQY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HQY. It does not provide personalized investment advice.